UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Long-Term Partial Remission with Capecitabine/ Trastuzumab in a Patient with Metastatic Breast Cancer Following Progression on Trastuzumab Alone

Breast care (Basel, Switzerland), 2012-02, Vol.7 (1), p.45-47

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-06-36: Assessment of phosphorylated HER2 protein as predictive biomarker to stratify anti-HER2 treatment in HER2 non-amplified patients – A translational study in the GeparQuattro and GeparQuinto trials

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-06-36

2015

Link zum Volltext

Verfügbarkeit prüfen

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

Geburtshilfe und Frauenheilkunde, 2018-10, Vol.78 (10), p.927-948

2018

Link zum Volltext

Verfügbarkeit prüfen

Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials

Oncotarget, 2018-03, Vol.9 (20), p.15168-15179

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.11505-11505

2016

Link zum Volltext

Verfügbarkeit prüfen

Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study

JNCI : Journal of the National Cancer Institute, 2008-04, Vol.100 (8), p.552-562

2008

Link zum Volltext

Verfügbarkeit prüfen

Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy Radiotherapy

Breast care (Basel, Switzerland), 2013-08, Vol.8 (4), p.270-275

2013

Link zum Volltext

Verfügbarkeit prüfen

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2017

Breast care (Basel, Switzerland), 2017-07, Vol.12 (3), p.172-183

2017

Link zum Volltext

Verfügbarkeit prüfen

AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017

Breast care (Basel, Switzerland), 2017-07, Vol.12 (3), p.184-191

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)

Geburtshilfe und Frauenheilkunde, 2015-06, Vol.75 (6), p.556-565

2015

Link zum Volltext

Verfügbarkeit prüfen

Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

Modern pathology, 2016-10, Vol.29 (10), p.1155-1164

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab: a translational project in the neoadjuvant GeparQuinto trial

British journal of cancer, 2012-09, Vol.107 (6), p.956-960

2012

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel-related side effects and their management

European Journal of Oncology Nursing, 2009-02, Vol.13 (1), p.49-59

2009

Link zum Volltext

Verfügbarkeit prüfen

HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer

Breast cancer research : BCR, 2013-02, Vol.15 (1), p.R11-R11, Article R11

2013

Link zum Volltext

Verfügbarkeit prüfen

Adherence to Treatment Guidelines in Breast Cancer Care – a Retrospective Analysis of the ‘Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie’

Breast care (Basel, Switzerland), 2008, Vol.3 (2), p.87-92

2008

Link zum Volltext

Verfügbarkeit prüfen

Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy

Breast care (Basel, Switzerland), 2011-01, Vol.6 (4), p.279-283

2011

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for metastatic breast cancer–report of a European expert panel

The lancet oncology, 2002-12, Vol.3 (12), p.719-727

2002

Link zum Volltext

Verfügbarkeit prüfen

The Breast Cancer Guideline of the German Gynecological Oncology Working Group (AGO) – History and Current Status

Breast care (Basel, Switzerland), 2006-08, Vol.1 (4), p.223-224

Minckwitz, Gunter von

2006

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based recommendations on treating locoregional and distant metastases of carcinomas of the breast

Zentralblatt für Gynäkologie, 2002-05, Vol.124 (5), p.284

2002

Link zum Volltext

Verfügbarkeit prüfen

Molecular basis for the development of novel taxanes in the treatment of metastatic breast cancer

European journal of cancer supplements, 2008-09, Vol.6 (10), p.3-11

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 498

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(444)
Mit Volltextzugriff
(487)

Publikationsform

Artikel
(461)
Buchkapitel
(34)
Bücher
(2)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Breast Care
(40)
Breast Cancer Research And Treatment
(38)
British Journal Of Cancer
(26)
Geburtshilfe Und Frauenheilkunde
(26)
Oncology
(15)
Bmc Cancer
(14)
Journal Of Cancer Research And Clinical Oncology
(12)
Cancers
(10)
International Journal Of Cancer
(10)
Breast
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Long-Term Partial Remission with Capecitabine/ Trastuzumab in a Patient with Metastatic Breast Cancer Following Progression on Trastuzumab Alone

Abstract P3-06-36: Assessment of phosphorylated HER2 protein as predictive biomarker to stratify anti-HER2 treatment in HER2 non-amplified patients – A translational study in the GeparQuattro and GeparQuinto trials

Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial

Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial

Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials

Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial

Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study

Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy Radiotherapy

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2017

AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)

Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab: a translational project in the neoadjuvant GeparQuinto trial

Docetaxel-related side effects and their management

HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer

Adherence to Treatment Guidelines in Breast Cancer Care – a Retrospective Analysis of the ‘Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie’

Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy

Chemotherapy for metastatic breast cancer–report of a European expert panel

AGO Recommendations for the Diagnosis and Therapy of Breast Cancer

The Breast Cancer Guideline of the German Gynecological Oncology Working Group (AGO) – History and Current Status

Evidence-based recommendations on treating locoregional and distant metastases of carcinomas of the breast

Molecular basis for the development of novel taxanes in the treatment of metastatic breast cancer

Suchergebnisse filtern